MIMICC Study in Patients With Colorectal Cancer

Recruiting now · Not applicable

Conditions studied: Colorectal Cancer, Colon Cancer, Rectal Cancers

In brief

This multicenter prospective interventional study will evaluate stool and saliva microRNA expression and microbiome composition in patients with histologically confirmed colon or rectal cancer during key phases of the diagnostic and therapeutic pathway. The study aims to confirm and refine molecular signatures associated with colorectal cancer, assess the diagnostic and prognostic potential of salivary biomarkers, and characterize dynamic molecular changes during treatment and follow-up

Key facts

Study ID
NCT07494201
Run by
Fondazione del Piemonte per l'Oncologia
People needed
2500
Starts
2025-09-15
Expected to finish
2028-06-30
Last updated by the study team
2026-03-27

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.